Kelly L Matson
Overview
Explore the profile of Kelly L Matson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
190
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Wen X, Lawal O, Belviso N, Matson K, Wang S, Quilliam B, et al.
Drug Saf
. 2021 Jun;
44(8):863-875.
PMID: 34100263
Introduction: Several studies have reported increasing prevalence of prescription opioid use among pregnant women. However, little is known regarding the effects of maternal opioid use on neurodevelopmental disorders in early...
12.
Matson K, Orr K, Marino C, Cohen L
Innov Pharm
. 2021 May;
10(4).
PMID: 34007596
Objective: The primary objective of this study was to measure the effect of an annual student pharmacist led elementary-school health education program by assessing children's comprehension of educational sessions. Secondary...
13.
Sun T, Buchanan A, Bratberg J, Patry E, Matson K
Prev Chronic Dis
. 2020 May;
17:E37.
PMID: 32441640
The Rx (prescription) for Addiction and Medication Safety (RAMS) program was developed during the 2017 through 2018 academic year to educate students from 6 selected Rhode Island public high schools...
14.
Meyers R, Thackray J, Matson K, McPherson C, Lubsch L, Hellinga R, et al.
J Pediatr Pharmacol Ther
. 2020 Apr;
25(3):175-191.
PMID: 32265601
Objectives: The safe use of medications in pediatric patients requires practitioners to consider the unique pharmacokinetics and pharmacodynamics of drugs prescribed in this age group. In an effort to create...
15.
Matson K, Johnson P, Tran V, Horton E, Sterner-Allison J
J Pediatr Pharmacol Ther
. 2019 Mar;
24(1):72-75.
PMID: 30837819
Limited guidance on opioid use exists in the pediatric population, causing medication safety concerns for pain management in children and adolescents. Opioid misuse and use disorder continue to greatly affect...
16.
Rx for addiction and medication safety: An evaluation of teen education for opioid misuse prevention
Patry E, Bratberg J, Buchanan A, Paiva A, Balestrieri S, Matson K
Res Social Adm Pharm
. 2018 Aug;
15(8):917-924.
PMID: 30076091
Background: Rhode Island (RI) ninth graders report lifetime nonmedical use of prescription opioids (NMUPO) of 8.9%. NMUPO is associated with transition to heroin use, opioid overdose, and death. Objectives: Measure...
17.
Fiorito T, Luther M, Dennehy P, LaPlante K, Matson K
Pediatr Infect Dis J
. 2017 Dec;
37(7):654-661.
PMID: 29280786
Background: Vancomycin is frequently used to treat methicillin-resistant Staphylococcus aureus infections in pediatric patients. Vancomycin exposure may lead to an increase in frequency of nephrotoxicity. Our aim was to conduct...
18.
Jacobson A, Matson K, Mathews J, Parkhill A, Scartabello T
Curr Pharm Teach Learn
. 2017 Nov;
9(1):60-65.
PMID: 29180156
Background And Purpose: To quantify the implementation of inclusive policies and benefits as well as institutional commitment to support LGBT faculty, staff, and students in pharmacy schools nationwide. Educational Activity...
19.
Matson K, Horton E, Capino A
J Pediatr Pharmacol Ther
. 2017 Mar;
22(1):81-83.
PMID: 28337087
Approximately 31.8% of U.S. children ages 2 to 19 years are considered overweight or obese. This creates significant challenges to dosing medications that are primarily weight based (mg/kg) and in...
20.
Akhlaghi F, Matson K, Mohammadpour A, Kelly M, Karimani A
Clin Pharmacokinet
. 2016 Nov;
56(6):561-571.
PMID: 27832452
The incidence of type 2 diabetes mellitus (T2DM) among children and adolescents has been rising. This condition is associated with obesity, and it's prevalence is higher among minority or female...